Xiaoyong Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Xiaoyong Wang has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Yoonha Hwang
Department of Medicine, Division of Rheumatology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA
24 shared publications - Ann Richmond
Department of Veterans Affairs, Tennessee Valley Healthcare System, Nashville, USA
23 shared publications - Chi Yan
Department of Veterans Affairs, Tennessee Valley Healthcare System, Nashville, USA
23 shared publications - Deanna N. Edwards
Department of Medicine, Division of Rheumatology, Vanderbilt University Medical Center, Nashville, USA
23 shared publications - Jin Chen
Program in Cancer Biology, Vanderbilt University, Nashville, Tennessee
23 shared publications - Verra M. Ngwa
Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA
23 shared publications
Latest Publications
- Open Access
- 2 July 2026
- Published by Elsevier in SSRN Electronic Journal
Loss of Arginase 2 Promotes Lung Metastasis in Immunocompetent Hosts via Nitric Oxide Synthase 2-Dependent Th17 Response
Distant metastasis is the leading cause of cancer-related mortality, yet how tumor-intrinsic metabolic enzymes regulate tumor-immune crosstalk during metastasis remains poorly understood. Using an in vivo CRISPR-Cas9 screen targeting metabolic genes in an orthotopic 4T1 mammary carcinoma model, we identified arginase 2 (ARG2) as a lymphocyte-dependent suppressor of lung metastasis. Loss of ARG2 enhanced spontaneous lung metastasis without affecting primary tumor growth or metastatic outgrowth following intravenous tumor cell injection, indicating a role in early metastatic dissemination. Mechanistically, ARG2 deficiency increased nitric oxide synthase 2 (NOS2) expression, nitric oxide production, cytosolic DNA accumulation, and activation of the cGAS-STING-NF-κB pathway, leading to inflammatory cytokine production. ARG2-deficient tumors exhibited enrichment of Th17 cells and reduced anti-tumor immune populations. Genetic deletion of NOS2 reversed these immune alterations and suppressed metastasis. Together, these findings identify a tumor cell-intrinsic ARG2-NOS2 axis that promotes metastasis through inflammatory remodeling of the tumor microenvironment.
- 2 July 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessLoss of Arginase 2 Promotes Lung Metastasis in Immunocompetent Hosts via Nitric Oxide Synthase 2-Dependent Th17 Response
Distant metastasis is the leading cause of cancer-related mortality, yet how tumor-intrinsic metabolic enzymes regulate tumor-immune crosstalk during metastasis remains poorly understood. Using an in vivo CRISPR-Cas9 screen targeting metabolic genes in an orthotopic 4T1 mammary carcinoma model, we identified arginase 2 (ARG2) as a lymphocyte-dependent suppressor of lung metastasis. Loss of ARG2 enhanced spontaneous lung metastasis without affecting primary tumor growth or metastatic outgrowth following intravenous tumor cell injection, indicating a role in early metastatic dissemination. Mechanistically, ARG2 deficiency increased nitric oxide synthase 2 (NOS2) expression, nitric oxide production, cytosolic DNA accumulation, and activation of the cGAS-STING-NF-κB pathway, leading to inflammatory cytokine production. ARG2-deficient tumors exhibited enrichment of Th17 cells and reduced anti-tumor immune populations. Genetic deletion of NOS2 reversed these immune alterations and suppressed metastasis. Together, these findings identify a tumor cell-intrinsic ARG2-NOS2 axis that promotes metastasis through inflammatory remodeling of the tumor microenvironment.
- Open Access
- 6 August 2024
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 178, 117221
Combining luteolin and curcumin synergistically suppresses triple-negative breast cancer by regulating IFN and TGF-β signaling pathways
- 6 August 2024
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 178, 117221
Open AccessCombining luteolin and curcumin synergistically suppresses triple-negative breast cancer by regulating IFN and TGF-β signaling pathways
- Open Access
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Materials and Methods1 from Loss of Vascular Endothelial Glutaminase Inhibits Tumor Growth and Metastasis, and Increases Sensitivity to Chemotherapy
This is additional Supplementary Materials and Methods including tables.
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Materials and Methods1 from Loss of Vascular Endothelial Glutaminase Inhibits Tumor Growth and Metastasis, and Increases Sensitivity to Chemotherapy
This is additional Supplementary Materials and Methods including tables.
- Open Access
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Fig. S6 from Loss of Vascular Endothelial Glutaminase Inhibits Tumor Growth and Metastasis, and Increases Sensitivity to Chemotherapy
This figure shows volcano plots of differentially expressed genes in GLSECKO versus WT endothelial cell, differentially enriched pathways up and down, Gene set enrichment analysis, -log FPKM of Gls, Gls2, angiogenic genes, qRT-PCR of leptin and angiogenic genes in GLSECKO versus WT.
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Fig. S6 from Loss of Vascular Endothelial Glutaminase Inhibits Tumor Growth and Metastasis, and Increases Sensitivity to Chemotherapy
This figure shows volcano plots of differentially expressed genes in GLSECKO versus WT endothelial cell, differentially enriched pathways up and down, Gene set enrichment analysis, -log FPKM of Gls, Gls2, angiogenic genes, qRT-PCR of leptin and angiogenic genes in GLSECKO versus WT.
- Open Access
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Supplementary RNA-seq Data RNA1 from Loss of Vascular Endothelial Glutaminase Inhibits Tumor Growth and Metastasis, and Increases Sensitivity to Chemotherapy
Excel file showing processed transcriptomics data from RNA-seq.
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary RNA-seq Data RNA1 from Loss of Vascular Endothelial Glutaminase Inhibits Tumor Growth and Metastasis, and Increases Sensitivity to Chemotherapy
Excel file showing processed transcriptomics data from RNA-seq.
- Open Access
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Fig. S2 from Loss of Vascular Endothelial Glutaminase Inhibits Tumor Growth and Metastasis, and Increases Sensitivity to Chemotherapy
This figure shows immunofluorescence images and quantification of CD31 and α-SMA in mammary gland, kidney, Lung and Liver tissues from non-tumor bearing mice after they were treated with tamoxifen.
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Fig. S2 from Loss of Vascular Endothelial Glutaminase Inhibits Tumor Growth and Metastasis, and Increases Sensitivity to Chemotherapy
This figure shows immunofluorescence images and quantification of CD31 and α-SMA in mammary gland, kidney, Lung and Liver tissues from non-tumor bearing mice after they were treated with tamoxifen.